InnoCare Pharma Limited

SEHK:9969 Stock Report

Market Cap: HK$13.1b

InnoCare Pharma Balance Sheet Health

Financial Health criteria checks 5/6

InnoCare Pharma has a total shareholder equity of CN¥6.8B and total debt of CN¥1.4B, which brings its debt-to-equity ratio to 20.9%. Its total assets and total liabilities are CN¥9.5B and CN¥2.6B respectively.

Key information

20.9%

Debt to equity ratio

CN¥1.42b

Debt

Interest coverage ration/a
CashCN¥7.08b
EquityCN¥6.82b
Total liabilitiesCN¥2.64b
Total assetsCN¥9.46b

Recent financial health updates

Recent updates

Is InnoCare Pharma (HKG:9969) A Risky Investment?

Oct 21
Is InnoCare Pharma (HKG:9969) A Risky Investment?

Subdued Growth No Barrier To InnoCare Pharma Limited (HKG:9969) With Shares Advancing 29%

Sep 13
Subdued Growth No Barrier To InnoCare Pharma Limited (HKG:9969) With Shares Advancing 29%

Analyst Estimates: Here's What Brokers Think Of InnoCare Pharma Limited (HKG:9969) After Its Half-Yearly Report

Aug 22
Analyst Estimates: Here's What Brokers Think Of InnoCare Pharma Limited (HKG:9969) After Its Half-Yearly Report

Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Jun 21
Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Some Analysts Just Cut Their InnoCare Pharma Limited (HKG:9969) Estimates

Apr 02
Some Analysts Just Cut Their InnoCare Pharma Limited (HKG:9969) Estimates

Is InnoCare Pharma (HKG:9969) Weighed On By Its Debt Load?

Feb 14
Is InnoCare Pharma (HKG:9969) Weighed On By Its Debt Load?

Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Oct 06
Health Check: How Prudently Does InnoCare Pharma (HKG:9969) Use Debt?

Is InnoCare Pharma (HKG:9969) Using Too Much Debt?

May 11
Is InnoCare Pharma (HKG:9969) Using Too Much Debt?

Is There An Opportunity With InnoCare Pharma Limited's (HKG:9969) 36% Undervaluation?

Apr 11
Is There An Opportunity With InnoCare Pharma Limited's (HKG:9969) 36% Undervaluation?

Is InnoCare Pharma (HKG:9969) A Risky Investment?

Jan 25
Is InnoCare Pharma (HKG:9969) A Risky Investment?

Despite Lacking Profits InnoCare Pharma (HKG:9969) Seems To Be On Top Of Its Debt

Sep 05
Despite Lacking Profits InnoCare Pharma (HKG:9969) Seems To Be On Top Of Its Debt

InnoCare Pharma (HKG:9969) Is Using Debt Safely

Apr 30
InnoCare Pharma (HKG:9969) Is Using Debt Safely

Financial Position Analysis

Short Term Liabilities: 9969's short term assets (CN¥7.9B) exceed its short term liabilities (CN¥1.0B).

Long Term Liabilities: 9969's short term assets (CN¥7.9B) exceed its long term liabilities (CN¥1.6B).


Debt to Equity History and Analysis

Debt Level: 9969 has more cash than its total debt.

Reducing Debt: 9969 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 9969 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 9969 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies